CD27 or TNFRSF7, is a type I transmembrane protein and TNF receptor that is expressed on subsets of T, B, NK, and hematopoietic progenitor cells. CD27 controls the activity of these cells by engaging with CD70, which is transiently expressed by cells of the immune system upon activation . Studies have demonstrated that the interaction between CD27 and its ligand, CD70, plays a role in providing costimulation for prolonged lymphocyte survival, enhanced T-cell proliferation, and memory-cell formation. Preclinical studies with fully-human agonistic antibodies to CD27 indicate that responses to CD27 stimulation are recapitulated by human lymphocytes in vitro and in vivo and can promote adaptive immunity in a variety of tumors models.
| Intended Use | IVD |
|---|---|
| Antibody Type | Polyclonal |
| Clone | Polyclonal |
| Source | Rabbit |
| Tissue Type/Cancer Type | Tonsil |
| Pack | 0.5 mL – Manual – Concentrate, 1 mL – Manual – Concentrate, 6 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 100 Tests – Automation – i6000, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
